Literature DB >> 27500550

Improved Computation of Protein-Protein Relative Binding Energies with the Nwat-MMGBSA Method.

Irene Maffucci1, Alessandro Contini1.   

Abstract

A MMGBSA variant (here referred to as Nwat-MMGBSA), based on the inclusion of a certain number of explicit water molecules (Nwat) during the calculations, has been tested on a set of 20 protein-protein complexes, using the correlation between predicted and experimental binding energy as the evaluation metric. Besides the Nwat parameter, the effect of the force field, the molecular dynamics simulation length, and the implicit solvent model used in the MMGBSA analysis have been also evaluated. We found that considering 30 interfacial water molecules improved the correlation between predicted and experimental binding energies by up to 30%, compared to the standard approach. Moreover, the correlation resulted in being rather sensitive to the force field and, to a minor extent, to the implicit solvent model and to the length of the MD simulation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27500550     DOI: 10.1021/acs.jcim.6b00196

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  12 in total

1.  Regulating the alky chain length of fatty acid-didanosine prodrugs and evaluating its role in albumin binding.

Authors:  Hongxiang Chen; Gang Wang; Lanzhen Sun; Huicong Zhang; Mengchi Sun; Jin Sun; Lei Shang; Cong Luo
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

2.  Substrate Selectivity of Coumarin Derivatives by Human CYP1 Enzymes: In Vitro Enzyme Kinetics and In Silico Modeling.

Authors:  Risto O Juvonen; Mira Ahinko; Elmeri M Jokinen; Juhani Huuskonen; Hannu Raunio; Olli T Pentikäinen
Journal:  ACS Omega       Date:  2021-04-19

3.  Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target.

Authors:  Silvia Giatti; Alessandro Di Domizio; Silvia Diviccaro; Eva Falvo; Donatella Caruso; Alessandro Contini; Roberto Cosimo Melcangi
Journal:  J Med Chem       Date:  2021-04-12       Impact factor: 7.446

4.  Molecular simulation studies of the interactions between the human/pangolin/cat/bat ACE2 and the receptor binding domain of the SARS-CoV-2 spike protein.

Authors:  Shaojie Ma; Hui Li; Jun Yang; Kunqian Yu
Journal:  Biochimie       Date:  2021-05-11       Impact factor: 4.079

5.  Statistical Analysis on the Performance of Molecular Mechanics Poisson-Boltzmann Surface Area versus Absolute Binding Free Energy Calculations: Bromodomains as a Case Study.

Authors:  Matteo Aldeghi; Michael J Bodkin; Stefan Knapp; Philip C Biggin
Journal:  J Chem Inf Model       Date:  2017-08-24       Impact factor: 4.956

6.  Molecular dynamics and in silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 main protease complexes reveal the role of lateral pocket in enhancing the ligand affinity.

Authors:  Ying Li Weng; Shiv Rakesh Naik; Nadia Dingelstad; Miguel R Lugo; Subha Kalyaanamoorthy; Aravindhan Ganesan
Journal:  Sci Rep       Date:  2021-04-01       Impact factor: 4.379

7.  Glycan Epitopes and Potential Glycoside Antagonists of DC-SIGN Involved in COVID-19: In Silico Study.

Authors:  Meina Gao; Hui Li; Chenghao Ye; Kaixian Chen; Hualiang Jiang; Kunqian Yu
Journal:  Biomolecules       Date:  2021-10-27

8.  An Efficient Implementation of the Nwat-MMGBSA Method to Rescore Docking Results in Medium-Throughput Virtual Screenings.

Authors:  Irene Maffucci; Xiao Hu; Valentina Fumagalli; Alessandro Contini
Journal:  Front Chem       Date:  2018-03-05       Impact factor: 5.221

9.  In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins.

Authors:  Irene Maffucci; Alessandro Contini
Journal:  J Proteome Res       Date:  2020-09-21       Impact factor: 4.466

10.  Non-natural 3-Arylmorpholino-β-amino Acid as a PPII Helix Inducer.

Authors:  Francesco Vaghi; Raffaella Bucci; Francesca Clerici; Alessandro Contini; M Luisa Gelmi
Journal:  Org Lett       Date:  2020-07-30       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.